In Partnership with:
3434 Stories, most recent news story added 18 minutes ago
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market.
Stem cell researchers at the Gladstone Institute in San Francisco and Stanford Medical School have joined a new national consortium linking teams of scientists who normally work independently with other groups that seek to discover new therapies for varied...
A gene associated with longevity in roundworms and humans has been shown to affect the function of stem cells that generate new neurons in the adult brain, according to researchers at the Stanford University School of Medicine. The study in mice suggests that the gene may play an important role in maintaining cognitive function during aging.
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.All fifty-eight patients, with a median age of 63 and all ...
PROVIDENCE – Rhode Island Hospital will receive $11 million over five years to develop a major stem-cell research center that will focus on stem-cell biology and tissue-regeneration techniques that could be used to treat marrow and lung diseases.
DUARTE - California's stem cell research program has awarded City of Hope two multi-million-dollar grants to develop treatments for brain cancer and HIV.
GOLDEN, Colo.----Vitro Diagnostics, Inc. , dba Vitro Biopharma, announced expansion of its core manufacturing capacity to meet growing demand for its “Tools for Stem Cell and Drug Development™” product line that was introduced earlier in the year.
At this crucial time, when the federal government is not funding any new human embryonic stem cell grants while federal guidelines are being organized, the Bedford Stem Cell Research Foundation's Seventh Annual Activated Egg Symposium is bringing together an elite group of speakers from Connecticut, Massachusetts and California to share their latest research with other scientists, mostly funded ...
CLEVELAND, Ohio -- Athersys Inc. continued enrollments during the third quarter in safety and efficacy trials of its adult stem cell therapy, MultiStem, for heart attack patients and those who run the risk of rejecting bone marrow transplants. At the same time, the clinical-stage biopharmaceutical company looked for money for a third trial involving stroke patients. "We believe MultiStem ...
Human embryonic stem cells may one day be used to help people recover abilities to learn and remember that are lost after radiation treatment for brain tumors, experiments on rats suggest.
The new market research report, 'Global Stem Cell and Advanced Technologies Market' (2009 - 2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com) analyzes the major trends in the global stem cell market.
California's stem cell funding agency giveth and it taketh away
Scientists in Belgium have successfully differentiated human embryonic stem cells (hESC) into major cell types of lung epithelial tissue using a convenient air-liquid interface.
Orcrist Bio Inc. a biotechnology company developing stem cell-mobilizing pharmaceuticals, congratulates Dr. Linda Pilarski on her receipt of the 2009 ASTech Foundation Outstanding Leadership in Alberta Technology Award.
Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed shareholder questions about its new laboratory in Las Vegas, and its recently refiled S1 with the SEC, in an interview of Matthew Schissler, founder and CEO, by ...
MSU researchers are concerned regulations on embryonic stem cell research proposed in a Michigan Senate Committee would interfere with their progress.
Open slideshowAFP/Getty Images/File
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
